Benzbromarone biotransformation is not related to polymorphic oxidation of sparteine. 1988

I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
Abteilung für Klinische Pharmakologie, Universität Heidelberg.

UI MeSH Term Description Entries
D008297 Male Males
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003647 Debrisoquin An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Debrisoquine,Tendor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001553 Benzbromarone Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout. Acifugan,Benzbromaron,Benzbromaron AL,Benzbromaron-Ratiopharm,Besuric,Desuric,Narcaricin,Urinorm,AL, Benzbromaron,Benzbromaron Ratiopharm
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
February 1982, Clinical pharmacology and therapeutics,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
January 1986, Progress in clinical and biological research,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
November 1986, British journal of clinical pharmacology,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
November 1985, Klinische Wochenschrift,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
July 1986, British journal of clinical pharmacology,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
April 1987, British journal of clinical pharmacology,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
January 1989, Therapeutic drug monitoring,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
May 1982, British journal of clinical pharmacology,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
January 1981, European journal of clinical pharmacology,
I Walter-Sack, and M Eichelbaum, and J X de Vries, and E Weber
August 1986, British journal of clinical pharmacology,
Copied contents to your clipboard!